Prevalence and Management of Incidental Testicular Masses-A Systematic Review

• Published in: Journal of clinical medicine Vol. 11; no. 19; p. 5770
• Main Authors: Henriques, Daniel, Mota Pinto, Anabela, Donato, Helena, Leão, Ricardo
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 29-09-2022; MDPI
• Subjects: Citation management software; Clinical medicine; Cryptorchidism; Histology; Infertility; Systematic Review; Testicular cancer; Tumors; Ultrasonic imaging; incidental findings; ultrasonography; testicular neoplasms; frozen sections; watchful waiting
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm11195770

Management of incidentally diagnosed small testicular masses (STM) is controversial. Although there is the risk of malignancy, it might be realistic to safely seek preservation of testicles bearing benign masses. This study aims to systematically evaluate the evidence regarding prevalence of STMs, their benign or malignant histology and their management. We conducted a systematic literature search for studies reporting small or incidental testicular masses and their management by radical orchiectomy, testis sparing surgery (TSS) or ultrasound (US) surveillance. We initially screened 2126 abstracts and from these, 57 studies met the inclusion criteria. Testicular masses were detected in 1.74% of patients undergoing US examination. Regarding STMs removed by surgery, 41.12% were benign. Intraoperative frozen section examination (FSE) is a reliable tool to discriminate between benign and malignant testicular masses (average 93.05% accuracy), supporting TSS. Benign lesions were associated with smaller diameter (<1 cm 68.78% benign), were often hypoechoic and exhibited regular margins on US. Conclusions: Small testicular masses are often benign. Clinical and US patterns are not accurate enough for including patients in surveillance protocols and TSS paired with FSE is pivotal for precluding the removal of testicles bearing benign lesions. Future research might unveil new imaging tools or biomarkers to support clinical management.